Large-scale proteomics project seeks cures for neurodegenerative diseases

IF 58.7 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nature Medicine Pub Date : 2025-07-15 DOI:10.1038/s41591-025-03807-3

Boris Decourt, Marwan N. Sabbagh, Michelle M. Mielke

引用次数: 0

Abstract

A new Global Neurodegeneration Proteomics Consortium provides a wealth of data to boost mechanistic understanding, biomarker research and drug development during aging and in neurodegenerative diseases — and dementia in particular.

Abstract Image

查看原文本刊更多论文

大规模蛋白质组学计划寻求神经退行性疾病的治疗方法

一个新的全球神经退行性蛋白质组学联盟提供了丰富的数据，以促进机制的理解，生物标志物的研究和药物开发在衰老和神经退行性疾病-特别是痴呆。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Medicine 医学-生化与分子生物学

CiteScore

100.90

自引率

0.70%

发文量

525

审稿时长

1 months

期刊介绍： Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.